Climaco John M
SEC insider (Form 3/4/5 filer). CIK 0001546797. Chief Executive Officer at CNS Pharmaceuticals, Inc. (CNSP) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 17, 2025. Located in HOUSTON, TX.
Companies Climaco John M has filed insider reports for
- CNS Pharmaceuticals, Inc. (CNSP): Director, Officer, Chief Executive Officer
- Moleculin Biotech, Inc. (MBRX): Director
Climaco John M
CIK: 0001546797
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Nov 17, 2025CNSP
CNS Pharmaceuticals, Inc.
AwardDirectOption to purchase common stock
9.8K shares- - Nov 12, 2025MBRX
Moleculin Biotech, Inc.
AwardDirectStock Options (right to buy)
150K shares- - Nov 4, 2024MBRX
Moleculin Biotech, Inc.
AwardDirectStock option (right to buy)
10K shares-
1-3 of 3 transactions